Topics:
Gastrointestinal Cancers • Medical Oncology • NCI-CCC Tumor Board Question • Indiana University • Cholangiocarcinoma • NCI-CCC GI Tumor Board Question
How do you choose between GAP or GP for patients with borderline resectable cholangiocarcinoma?
GAP - Gemcitabine, cisplatin, nab-paclitaxel
GP - Gemcitabine, cisplatin
How does SWOG 1518 data impact your decision?